KDNY
Chinook Therapeutics Inc
Price:
40.39
USD
Volume:
4,923,690
United States | Biotechnology
KDNY Current Ratio
As of 2025-05-31, the Current Ratio of Chinook Therapeutics Inc (KDNY) is 7.59.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
KDNY Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2022-12-31 | 7.59 |
| 2021-12-31 | 7.5 |
| 2020-12-31 | 11.14 |
| 2019-12-31 | 10.09 |
| 2018-12-31 | 9.28 |
| 2017-12-31 | 8.46 |
| 2016-12-31 | 11.59 |
| 2015-12-31 | 13.65 |
| 2014-12-31 | 2.83 |
| 2013-12-31 | 0.65 |
KDNY Current Ratio - Peers Comparison